Document is current

Any future updates will be listed below

From Lab Formulation Development to CTM Manufacturing of KO-947 Injectable Drug Products: a Case Study and Lessons Learned

Crossref DOI link: https://doi.org/10.1208/s12249-021-02059-x

Published Online: 2021-06-02

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark